Intermittent interferon and polychemotherapy in metastatic melanoma
- 1 March 1995
- journal article
- clinical trial
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 121 (3) , 175-180
- https://doi.org/10.1007/bf01198100
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Treatment of patients with metastatic melanoma with a one day regimen of dacarbazine, vincristine, bleomycin and lomustine plus interferon-αEuropean Journal Of Cancer, 1994
- Advances in systemic treatment of malignant melanomaEuropean Journal Of Cancer, 1993
- Treatment of Metastatic Malignant Melanoma with Dacarbazine plus TamoxifenNew England Journal of Medicine, 1992
- Chemotherapy for advanced malignant melanomaInternational Journal of Clinical and Laboratory Research, 1992
- Interferon alpha2a and vindesine in the treatment of advanced malignant melanomaEuropean Journal Of Cancer, 1992
- A phase II study of metastatic melanoma treated with a combination of interferon Alfa2b, dacarbazine and nimustineEuropean Journal Of Cancer, 1992
- Brain metastases of malignant melanoma in interferon complete responders: clinical and radiological observationsJournal of Neuro-Oncology, 1992
- Interferon alfa-2b in addition to chlorambucil in the treatment of follicular lymphoma: Preliminary results of a randomized trial in progressEuropean Journal of Cancer and Clinical Oncology, 1991
- Recombinant interferon alfa-2a in advanced malignant melanoma. a phase i-ii study in combination with dticInternational Journal of Cancer, 1987
- Reporting results of cancer treatmentCancer, 1981